Key result
Daily hemodialysis stops the progression of cardiac hypertrophy in uremic patients and reverts it toward normality by improving blood pressure control.
Why the study?
Does daily hemodialysis improve or reverse cardiac hypertrophy in ESRD patients?
Population
End-stage renal disease (ESRD) / uremic patients on dialysis
Comparison
Daily hemodialysis vs Current standard dialytic treatments
Design
Review
Authors
Loading...
May support daily hemodialysis for LVH regression in ESRD; leaves open randomized confirmation.
Does daily hemodialysis improve or reverse cardiac hypertrophy in ESRD patients?
Daily hemodialysis may reverse left ventricular hypertrophy in ESRD patients by providing superior blood pressure and dry weight control compared to standard dialysis schedules.
Buoncristianí et al. (1999) conducted a review in End-stage renal disease (ESRD) with cardiac hypertrophy. Daily hemodialysis vs. Standard dialytic treatments was evaluated on Progression of cardiac hypertrophy. Daily hemodialysis stops the progression of cardiac hypertrophy in uremic patients and reverts it toward normality by improving blood pressure control.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: